NuGEN Technologies Inc. Announces Issuance of US Patent for Its Single Primer Target Enrichment Technology (SPET) for Next Generation Sequencing Applications
San Carlos, California , May 30, 2017 NuGEN Technologies today announced that the United States Patent and Trademark Office has issued US Patent No. US 9,650,628 describing the Single Primer Target Enrichment Technology (SPET) which enables targeted nucleic acid analysis by next generation sequencing (NGS). NuGEN offers commercial solutions using SPET to create target and strand-specific libraries... Read more